TY  - GEN
AU  - Suri,Ajit
AU  - Mould,Diane R
AU  - Liu,Yi
AU  - Jang,Graham
AU  - Venkatakrishnan,Karthik
TI  - Population PK and Exposure-Response Relationships for the Antibody-Drug Conjugate Brentuximab Vedotin in CTCL Patients in the Phase III ALCANZA Study
SN  - 1532-6535
PY  - 2019///0924
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Immunological
KW  - administration & dosage
KW  - Brentuximab Vedotin
KW  - Child
KW  - Clinical Trials, Phase III as Topic
KW  - Computer Simulation
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Dosage Calculations
KW  - Drug Monitoring
KW  - Female
KW  - Humans
KW  - Immunoconjugates
KW  - Lymphoma, T-Cell, Cutaneous
KW  - blood
KW  - Male
KW  - Middle Aged
KW  - Models, Biological
KW  - Progression-Free Survival
KW  - Risk Assessment
KW  - Skin Neoplasms
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cpt.1037
ER  -